White label – Pompe disease - ClinicalTrials.eu

Study on the Safety and Effects of AZD7789 for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Not recruiting

1 1 1 1
Investigated Diseases:
- Hodgkin’s disease
Investigated Drugs:
Study of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy

Not recruiting

3 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
+5
Study on the Effects and Safety of Crovalimab for Adults and Adolescents with Atypical Hemolytic Uremic Syndrome (aHUS)

Not recruiting

3 1 1
Investigated Diseases:
- Atypical haemolytic uraemic syndrome
Investigated Drugs:
- Crovalimab
+1
Study of Tocilizumab Treatment for Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients

Not recruiting

3 1 1 1
Investigated Diseases:
- Kidney transplant rejection
- Renal transplant
Investigated Drugs:
- Tocilizumab
Study Comparing Nivolumab and Ipilimumab with Chemotherapy to Chemotherapy Alone for Patients with Stage IV Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer stage IV
Investigated Drugs:
+1
Study on the Effectiveness of Apalutamide in Men with Castration-Resistant Prostate Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Prostate cancer metastatic
Investigated Drugs:
+6
Study of Apalutamide and Androgen Deprivation Therapy for Patients with Metastatic Hormone-sensitive Prostate Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Prostate cancer metastatic
Investigated Drugs:
- Apalutamide
Study of Tobemstomig with Platinum-Based Chemotherapy vs Pembrolizumab with Platinum-Based Chemotherapy for Untreated Non-Small Cell Lung Cancer Patients

Not recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Study on the Safety and Effectiveness of LASN01 for Patients with Thyroid Eye Disease

Not recruiting

2 1 1
Investigated Diseases:
- Endocrine ophthalmopathy
Investigated Drugs:
Study Comparing Sonrotoclax and Zanubrutinib with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia

Not recruiting

3 1 1 1
Investigated Drugs:
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies